| Literature DB >> 8557260 |
E Reyniers1, D R Van Bockstaele, K De Boulle, R F Kooy, C E Bakker, B A Oostra, P J Willems.
Abstract
A slight increase in mean corpuscular hemoglobin (MCH) has been reported in erythrocytes from human fragile X patients. As it is difficult to perform case-controlled studies in patients with fragile X syndrome, we studied MCH in erythrocytes from transgenic mice with an Fmr1 knockout. None of the knockout mice showed increased MCH levels when compared with normal littermates. We conclude that it is unlikely that the FMR1 gene product has an effect on MCH.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8557260 DOI: 10.1007/bf00218832
Source DB: PubMed Journal: Hum Genet ISSN: 0340-6717 Impact factor: 4.132